Followers | 104 |
Posts | 2500 |
Boards Moderated | 0 |
Alias Born | 12/02/2016 |
![](https://investorshub.advfn.com/uicon/585878.png?cb=1503666645)
Wednesday, January 24, 2018 3:37:02 PM
So in knowing that the South African government is back in session as of January 23, we are then to understand that the MCC will be resuming the work they had prior to their recess. Shouldn't be much longer, as all the pieces are in place from a legislative standpoint:
http://www.mccza.com/documents/2674952b2.44_Cannabis_cultivation_Sept17_v2.pdf
In addition, the Medicines Act allows the MCC to issue a licence to manufacture either a medicine or a Scheduled substance (Active Pharmaceutical Ingredient/API). Section 22C(1)(b) of the Medicines Act enables the cultivation and manufacture of Scheduled substances and ensures the required oversight of the MCC in regulating these activities. This provision allows the MCC to license cultivators of Cannabis for medicinal use and enables regulatory oversight in a way that is compliant with South Africa’s international obligations.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM